2 Min(s) Read
Krka is eyeing the acquisition to get a strong foothold in the US and Latin American markets, as Unichem Labs has a strong presence in the cardiology, diabetes, neurology, and anti-infective segments, among others.
Unichem Laboratories Ltd., a leading manufacturer of active pharmaceutical ingredients, was in focus on Monday after news emerged that Slovenian pharma company Krka, d.d., Novo Mesto was in discussions with the company to buy out its promoter’s stake.
An Economic Times report claimed, quoting people aware of the development, said that the Slovenian pharmaceutical company is in discussions to acquire the promoter’s stake in Unichem Labs.
CNBC-TV18 has not verified this report independently.